Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Key Companies Innovating in GLP-1 Obesity Treatments In 2025, the landscape of obesity treatment is being reshaped by innovative companies developing GLP-1 (glucagon-like peptide-1) receptor agonists
Nat Reviews Disease Primers
When you start shedding pounds quickly your brain hits the panic button
3 * Based on the efficacy estimand: estimated efficacy in an idealized scenario in which all patients stayed on treatment and without initiation of additional glucose-lowering medication
US$ 21.18
US$ 21.92
US$ 28.97
US$ 21.59
US$ 29.06
US$ 26.42
